CATALYST PHARMACEUTICALS, INC.
Ticker: 1369568
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 149.39+0.7% | 148.39+1.2% | 146.56+3.6% | 141.42+9.9% | 128.70+4.9% | 122.71+24.6% | 98.51-4.1% | 102.69 |
| Total Income | 149.39+0.7% | 148.39+1.2% | 146.56+3.6% | 141.42+9.9% | 128.70+4.9% | 122.71+24.6% | 98.51-4.1% | 102.69 |
| EXPENSES | ||||||||
| Expenditure | 76.16-7.3% | 82.13+2.3% | 80.27+2.8% | 78.05+0.3% | 77.79+13.6% | 68.46-4.1% | 71.38-49.0% | 139.88 |
| Tax | 20.50+12.3% | 18.25+6.2% | 17.19+18.1% | 14.55+9.2% | 13.32-11.1% | 14.99+158.0% | 5.81+180.0% | -7.26 |
| PROFIT | ||||||||
| PBT | 84.23+18.6% | 71.04+2.5% | 69.29-2.8% | 71.29+24.6% | 57.21+2.5% | 55.79+91.8% | 29.09+176.5% | -38.02 |
| Net Profit | 63.73+20.7% | 52.78+1.3% | 52.11-8.2% | 56.74+29.3% | 43.88+7.6% | 40.79+75.2% | 23.28+175.7% | -30.76 |
| KEY METRICS | ||||||||
| OPM % | 49.02%+4.36pp | 44.66%-0.58pp | 45.23%+0.43pp | 44.81%+5.25pp | 39.56%-4.65pp | 44.21%+16.67pp | 27.54%+63.75pp | -36.22% |
| NPM % | 42.66%+7.09pp | 35.57%+0.02pp | 35.55%-4.57pp | 40.12%+6.02pp | 34.10%+0.85pp | 33.24%+9.62pp | 23.63%+53.59pp | -29.96% |
| EPS | 0.52+20.9% | 0.43+0.0% | 0.43-8.5% | 0.47+27.0% | 0.37+5.7% | 0.35+75.0% | 0.20+169.0% | -0.29 |
Corporate Events
Board MeetingCPRX
202612May
Board Meeting
Cancellation of Q1 2026 earnings conference call due to pend…
SEC Filing ↗